Investor Meets | RPG Life Sciences
rpgls
  • Contact Us
  • Our Story
    • History and Milestones
    • Our Brand
    • Core Strengths
    • Vision, Values and Capabilities
    • Board of Directors
    • Management Team
    • Industry Awards and Recognition
  • Our Businesses
    • Business Portfolio
      • API
      • Domestic Formulations
      • International Formulations
      Manufacturing
      • Manufacturing Facilities
      • Quality
      • Environment, Health and Safety
      Scientific Overview
      • Research and Development
      • Patents
  • Therapeutic Focus
    • Nephrology
    • Cardiovascular
    • Anti-Diabetic
    • Orthopedic
    • Urology
    • Oncology
    • Rheumatology
    • Gastroenterology
    • Respiratory
    • Gynaecology and Pediatrics
    • Vitamins and Minerals
    • Neurology
    • Anti-Dengue
    • Dermatology
  • Life@RPGLS
    • Employee Connect
      Rewards and Recognition
      • Brave RPGLS Covid Warriors
      • Great Place To Work
      • Team Awards
      • Employee Awards
      Human Resources
      • Jobs At RPGLS
      • Company Events
      • Learning and Development
      CSR
      • Corporate Social Responsibility
      Explore Us
      Happiness Matters!!
  • Investors
    • Financial Results
      • Audited Financial Results
      • Quarterly Financial Results
      Company Presentations
      • Investor Presentations
      • Earnings Call
      • Press Release
      Mandatory Disclosures
      • Code and Policies
      Shareholders Information
      • Shareholding Pattern
      • Concepts and Procedure
      • Corporate Governance Reports
      • Annual Reports
      • Intimation to Stock Exchange
      • Notices of Board Meetings
      • Outcome of Board Meetings
      • AGM & Postal Ballot
      • Unpaid Dividend List
      • TDS on Dividend Communication
      • Forms related to Physical Shares
      • Newspaper Publications
      • Market Tracker and Credit Rating
      Investor Relations
      • Investor Education and Protection Fund
      • Investor Grievance
      • Investor Contacts
      • Investor Meets
      Committees Composition
      • Audit Committee
      • Risk Management Committee
      • Stakeholders Relationship Committee
      • Nomination & Remuneration Committee
      • SCSR Committee
      DISCLOSURES UNDER REGULATION 46 OF LODR
      • Disclosures under regulation 46 of LODR
  • Media
    • Online News and Print Media
    • RPGLS @ Industry Platforms

INVESTOR MEETS
  • Home
  • investor meets

Sr. No. File Name (Click to Download)
1 Investor meet intimation_22.05.2026
2 Intimation of Earning Call_ 23.04.2026
3 Intimation of Earning Call_ 17th Oct 25
4 Intimation of Earnings Call_october 17,2025
5 Investor Meet- September 4th, 2025
6 Institutional Investor meet_22.08.25
7 Intimation of Investor Meet 25.02.2025
8 Intimation of Investor Meet_16.12.2024
9 Intimation of Analyst Meeting_13.09.2024
10 Intimation of Institutional Investor Meet September 18, 2024
11 Intimation of Institutional Investor Meet September 04, 2024
12 Cancellation of Analyst Institutional Investors meet 12th August 2024
13 Intimation of Institutional Investor Meet Aug 12, 2024.pdf
14 Intimation of Institutional Investor Meet_June_7, 2024
15 Intimation of Institutional Investor Meet_February 29, 2024
  • 1
  • 2
  • 3
  • Next

Investors Information

Annual Conference Videos
  • June 16, 2021
  • Your browser does not support HTML5 video.
Company Presentations
  • Investor Presentations
  • Corporate Presentations
  • Earnings Call
  • Press Release
Financial Results
  • Audited Financial Results
  • Quarterly Financial Results
  • Dividend Declarations
Investor Relations
  • Investor Education and Protection Fund
  • Investor Grievance
  • Investor Contacts
  • Investor Meets
Share Holders Information
  • Shareholding Pattern
  • Concepts and Procedure
  • Corporate Governance Reports
  • Annual Reports
  • Intimation to Stock Exchange
  • Notices of Board Meetings
  • Outcome of Board Meetings
  • AGM & Postal Ballot
  • Unpaid Dividend List
  • TDS on dividend communication
  • Forms related to Physical Shares
  • Reg. 46 SEBI (LODR)
  • Newspaper Publications
  • Market tracker
Board Committees
  • Audit Committee
  • Risk Management Committee
  • Stakeholders Relationship Committee
  • Nomination & Remuneration Committee
  • SCSR Committee
Mandatory Disclosures
  • Code and Policies
  • Disclosures under regulation 46 of LODR
Get in Touch

QUICK LINKS

Vision

Quality

History and Milestones

Company Awards

Manufacturing Facilities

Research and Development

Offline PDF form
Drugs Safety – Adverse Event Reporting

Contact Us

  • Address:
    RPG Life Sciences Limited,
    RPG HOUSE, 463, Dr. Annie Besant Road, Worli,
    Mumbai - 400030, India

  • Phone: 91-22-69757100

  • Email:

Follow Us




Porto Website Template

RPG Life Sciences Limited © Copyright 2025-26. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Sitemap